3rd Quarter - Amendment

CAPITOL HILL CONSULTING GROUP for ENDO PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 19, 2015 $50,000 Replaced
3rd Quarter - Amendment (this page) Jan 24, 2018 $50,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to incentives for life sciences research H.R. 160- Protect Medical Innovation Act of 2015 H.Res106 Prostate Cancer Survivors Quality of Life Act Medical Device Tax Repeal Stop Corporate Inversions Act S.2360, H.R.4679

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN —
BILL K BREWSTER —
DAVID JORY —
BRIAN SUTTER New Staff Dir., W&M Health Subcommittee, Chrman Dave Camp April'13-Dec.'14 Professional Staff, W&M Health Subcommittee, Chrman Dave Camp, Jan'11-April'13 Leg Dir. Rep. Dave Camp, May'08-Jan'11 Leg Asst Rep. Dave Camp, Feb'03-May'08; Staff Ast July'02-

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4679 (114th), S. 2360 (114th), H.Res. 106 (114th), H.R. 160 (114th)

Health Issues HCR

Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Issues relating to health information technology. Compounding and drug supply chain legislation. H.R.471 -Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; General Health issues, including but not limited to, coverage and reimbursement; drug

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN —
BILL K BREWSTER —
DAVID JORY —
BRIAN SUTTER New Staff Dir., W&M Health Subcommittee, Chrman Dave Camp April'13-Dec.'14 Professional Staff, W&M Health Subcommittee, Chrman Dave Camp, Jan'11-April'13 Leg Dir. Rep. Dave Camp, May'08-Jan'11 Leg Asst Rep. Dave Camp, Feb'03-May'08; Staff Ast July'02

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.Res. 106 (114th), H.R. 471 (114th)

Copyright/Patent/Trademark CPT

Oversight of implantation of the America Invents Act Issues relating to patent settlements H.R.9-The Innovation Act

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN —
BILL K BREWSTER —
DAVID JORY —
BRIAN SUTTER New Staff Dir., W&M Health Subcommittee, Chrman Dave Camp April'13-Dec.'14 Professional Staff, W&M Health Subcommittee, Chrman Dave Camp, Jan'11-April'13 Leg Dir. Rep. Dave Camp, May'08-Jan'11 Leg Asst Rep. Dave Camp, Feb'03-May'08; Staff Ast July'02-

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th)

Pharmacy PHA

Issues related to tamper resistant formulation of pharmaceutical and generic drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825

LobbyistCovered position, as disclosed
CHRISTOPHER BOWLIN —
BILL K BREWSTER —
DAVID JORY —
BRIAN SUTTER New Staff Dir., W&M Health Subcommittee, Chrman Dave Camp April'13-Dec.'14 Professional Staff, W&M Health Subcommittee, Chrman Dave Camp, Jan'11-April'13 Leg Dir. Rep. Dave Camp, May'08-Jan'11 Leg Asst Rep. Dave Camp, Feb'03-May'08; Staff Ast July'02

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2825 (114th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.